View More
In this on-demand webcast from a live meeting, oncology expert Jesús G. Berdeja, MD, discusses current best practices in the use of CAR T-cell therapy to treat patients with hematologic malignancies.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.